44results about How to "Inhibits mitosis" patented technology

The invention discloses a pharmaceutical for treating cancer and a preparation method thereof. The pharmaceutical is prepared from taxus, reed root, shinyleaf pricklyash root, cicada slough, medicinai changium root, manyprickle acathopanax root, isatis leaves, polygala root, umbrella polyporus, hirtellous clover-shrub root, tortoise shell, poria, snakegourd fruit, alpine yarrow herb, common portulaca, arisaema tuber, zedoary turmeric rhizome, spatholobus stem, natural indigo, self-heal, long-noded pit viper, rhubarb, subprostrate soplhor root, dandelion, polyphylla, kosam seed, wild glossy ganoderma, centipede, giant knotweed, airpotato yam, Sichuan clematis stem, sun spurge, ricepaper plant pith, medlar, largehead atractylodes rhizome, garden burnet root, schisandra fruit, oldenlandia,daxie, pilose asiabell root, grassleaved sweetflag, lycoris, ledebouriella root, brown lily and TAXEL by mixing proportionally. The pharmaceutical can be used for treating various cancers, especially for treating advanced cancers such as leukaemia with high leucocyte content and cancer metastasis to bones.

The invention discloses a method for culturing triploid petunia. The method comprises the following steps: selecting a diploid petunia combination with strong heterosis as a crossing parent, selecting proper flower buds in the flowering period of a male parent, carrying out chemical mutagenesis by adopting mixed liquid of colchicine, oryzalin and trifluralin to generate 2n pollens, pollinating the 2n pollens to a diploid female parent stigma to obtain F1 hybridized seeds, and hybridizing n pollens the male parent of which is not subjected to chemical mutagenesis with the female parent to obtain contrast diploid F1 hybrid seeds. The adult plants developed from the F1 hybridized seeds are compared with the contrast diploid F1 hybridized filial generations in the aspects of agronomic trait and anatomy, and on this basis, the number of chromosomes can be detected so as to finally determine the triploid plant. According to the method disclosed by the invention, the breeding period is short, the operation is convenient, the mutagenesis efficiency is high and the application prospect is good.

The invention relates to a health-care drink, wherein it uses yew as main material. And the production comprises that: washing yew skin, branch, leaf, root, corn and bud, removing foreign material and mud, to prepare the mother liquid; mixing mother liquid with drink at 1:30-50 volume ratios; disinfecting, bottling. The invention has low cost and health-care function.

The invention provides a new medicament for treating leukemia, which is prepared from 39 raw material drugs, such as taxus chinensis (tree bark), tender catchweed bedstraw herb, prismatomeria tetrandra, isatis indigotica fort, tuber fleeceflower stem, Yunnan fringed iris herb, fructus corni, hemlock parsley, turtle shell and the like, wherein the taxus chinensis (tree bark) contains 'taxol' which is the top anti-cancer medicament in the world, can be combined with trace of albumin, so that the albumin is accelerated to be aggregated, mitosis of cancer cells can be inhibited, and proliferation of the cancer cells can be effectively stopped. The medicament also comprises the tender catchweed bedstraw herb, suncured ginseng, prismatomeria tetrandra, isatis indigotica fort, tuber fleeceflower stem, Yunnan fringed iris herb, fructus corni, hemlock parsley and turtle shell, so that growth and development of the cancer cells can be controlled, the cancer resistance of a human body can be reinforced, the circulation and metabolic function of the human body can be improved, virus accumulated in the human body is removed outside the body through urine and defecation to achieve the function of preventing cancer. The medicament adopts the Chinese medicaments capable of nourishing yin and supplementing kidney, supplying vital energy, nourishing and activating blood, tonifying qi and controlling blood, softening hardness to dissipate stagnation, removing toxicity and tonifying middle-Jiao and coordinating drug actions of a prescription, administration is increased or reduced according to the course development and classification of the leukemia to achieve the best treatment effect. 38 leukemia cases are treated non-selectively in clinical application, and the total effective rate is over 90 percent.

The invention relates to new applications of radix notoginseng and a radix notoginseng extract, namely new applications of radix notoginseng and the radix notoginseng extract to preparation of medicines for treating psoriasis, and in particular relates to a new application of a medicinal preparation with the content of ginsenosides Rb in the radix notoginseng extract not lower than 35% to preparation of medicines for treating psoriasis. The radix notoginseng ethanol extract obtained by extracting radix notoginseng with ethanol, adjusting the pH value of the extracting solution and carrying out adsorption with macroporous resin and carrying out elution can obviously inhibit mitosis of vaginal epithelia of mice and has obvious promoting effects on formation of granular layers of tail scales of C57 mice. The above results prompt that the radix notoginseng ethanol extract has the function of treating psoriasis.

The invention relates to platinum drugphotosensitizer-loaded protein nanoparticles and a preparation method and application thereof. The platinum drugphotosensitizer-loaded protein nanoparticles comprise platinum drugphotosensitizer complexes and proteins wrapping the platinum drugphotosensitizer complexes. Chemical therapy and photodynamic therapy are combined through an albumin nano-drug delivery system so that a synergistic anti-cancer effect is achieved, and the toxicity-reducing and efficacy-improving treatment effect is achieved. The nanoparticles prepared by the method are small in particle size, uniform in dispersion and round in shape; good chemical stability and illumination stability are realized; under the irradiation of near-infrared light, the nanoparticles have relatively high active oxygen generation capability; in addition, in cell experiments and animal experiments, it is verified that the nanoparticle has strong cytotoxicity and good in-vivo tumor targeting to tumorcells, plays a synergistic effect, reduces toxic and side effects, realizes combined treatment of tumors by chemotherapy and photodynamic therapy, and inhibits tumor metastasis.

The invention relates to a novel medicine for treating leukemia and a preparation method thereof and belongs to the technical field of traditional Chinese medicines. The medicine is prepared into different preparations by the conventional method in the following steps: by taking taxus chinensis, sculellaria barbata, oldenlandia diffusa, trigone, curcuma zedoary and silkworm bombycis as main materials and cleavers, American ginseng, prismatomeria tetrandra, isatis roots, tuber fleeceflower stems, Tupistra fimbriata Hand.Mazz., fructus corni, lucid ganoderma, human placenta, ligusticum wallichii and turtle shells as auxiliary materials, dosing; drying; respectively grinding fine powder; uniformly mixing; and then steaming and basking for three times. As taxus chinensis contains the No.1 anti-cancer drug in world: paclitaxel and the auxiliary materials assist, growth and development of cancer cells can be controlled, the anticancer ability of human body is boosted, and meanwhile, cyclic and metabolic functions of the human body can be further enhanced, so that viruses accumulated in the human body are eliminated outside by diuresis and defecation so as to realize the effect of treating leukemia. According to clinical trails, the total effective rate is over 90%. The medicine has the best curative effect on acute myelocytic leukemia, myelodysplastic syndromes and graft-versus-host disease, the second effect on polycythemia vera and chronic myelognous leukia, and then acute promyelocytic leukemia.

The invention relates to a warehouse bacteriostatic herbicide; the Warehouse bacteriostatic herbicide is characterized in that the herbicide is prepared from, by mass, 10-25 parts of glufosinate-ammonium, 10-30 parts of semen strychni extractive, 1-10 parts of fructus kochiae extractive, 0.8-3.5 parts of surface active agent, 0.4-3 parts of thickening agent, 0.4-3 parts of solvent, 1-2 parts of antifoaming agent, 0.8-4 parts of bentonite, and 1-5 parts of cupric sulfate monohydrate. The invention further provides a preparation method of the warehouse bacteriostatic herbicide. The warehouse bacteriostatic herbicide is good in effect of weeding, simple in preparation method, and easy to popularize.

The invention provides a high-quality automatic roxburgh anoectochilus terminal bud breeding technology. A traditional roxburgh anoectochilus terminal bud breeding technical form is broken through, and protocorms subjected to chromosome doubling treatment are placed into a cluster culture medium and continue to be cultured to obtain clustered buds; the clustered buds are divided, transferred intoa rooting medium and cultured to obtain tissue culture seedlings with complete roots, stems and leaves; the tissue culture seedlings are screened to obtain polyploid plants; at least one robust targetpolyploid plant is selected from the polyploid plants; a plurality of target seedlings are cultured by the aid of the target polyploid plant; the target seedlings are bred and cultured in a multi-parameter variation manner by an intelligent breeding mechanism to obtain target roxburgh anoectochilus terminal bud seedlings; at least one strongly growing target roxburgh anoectochilus terminal bud seedling is selected, and parameters of the growth environment of the target roxburgh anoectochilus terminal bud seedling are recorded as standard growth environment parameters after a certain time. Therefore, the environment adapts to varieties, the optionally selected varieties are under optimal growth conditions, optimal growth quality is achieved, and breeding efficiency can be more effectivelyimproved.

The invention relates to the technical field of traditional Chinese medicines. A traditional Chinese medicine for treating hyperplasia of mammary glands is characterized in that the medicine is prepared from the following raw drugs: by weight, 10g of radix paeoniae rubrathe, 15g of radix bupleuri, 10g of frankincense, 15g of semen citri reticulatae, 10g of Chinese angelica, 15g of the seed of cowherb, 5g of Poria cocos, 10g of bitter orange, 20g of red sage root, 5g of green tangerine peel, 10g of Sinapis alba, 15g of honeycomb and 20g of barbat skullcap. Through dialectical compatibility, components of the traditional Chinese medicine provided by the invention are complementary in functions, have synergistic effects, and have efficacy of soothing the liver and resolving depression, reducing phlegm and removing stasis, softening hardness and dissipating binds, invigorate blood circulation and relieving pain and the like. By the adoption of the traditional Chinese medicine, immunity of the organism can be raised, endocrine function is balanced, and hyperplastic tissues are eliminated so as to reach the purpose of treating hyperplasia of mammary glands.

The invention relates to a magnesium isoglycyrrhetate emulsifiable paste preparation which contains the magnesium isoglycyrrhetate, a water-in-oil type substrate and a pH regulator; wherein, the weight of the magnesium isoglycyrrhetate accounts for 1 to 10 percent and the pH value is 6.5 to 8; an emulsifier used in the water-in-oil type substrate is span 80 and monostearin.

The invention relates to the field of plant culture and particularly relates to a culturing method of a polyploid anoectochilus roxburghii variety. The culturing method comprises the following steps of culturing a diploid anoectochilus roxburghii seed to obtain a protocorm; soaking the protocorm in 5-15mu mol / L of an oryzalin solution to treat for 10-36 hours; further culturing the soaked protocorm to obtain a clustered shoot; after dividing, transferring the clustered shoot to a rooting medium to culture to obtain a tissue culture seedling with complete root, stem and leaves; and sieving the tissue culture seedling to obtain a polyploid plant. According to the culturing method of the polyploid anoectochilus roxburghii variety, provided by the invention, the anoectochilus roxburghii protocorm with very strong dividing capacity is used as an inducing material, the protocorm is soaked for the specific time by using the oryzalin solution with the specific concentration, and then, a polyploid anoectochilus roxburghii plant can be obtained through screening in cultured plants, wherein the induction rate ranges from 43.2% to 44.8%, and the obtained polyploid anoectochilus roxburghii plant is favorable in character.

The invention discloses a medicine composition, and in particular relates to a traditional Chinese medicine composition for treating psoriasis, a method for preparing the traditional Chinese medicine composition, and a quality testing method thereof, and belongs to the field of traditional Chinese medicine. The effective components of the medicine composition are prepared from Rehmannia glutinosa, angelica dahurica, tortoiseshells, Paeonia lactiflora, artificial bezoar, schizonepeta spikes and other raw material medicines, and prepared into tablets, capsules, granules, pills and other preparation formulations according to clinical demands. The medicine composition has obvious function of treating or improving psoriasis.